Rosacea in Crohn's Disease: Effect of Rifaximin

J Clin Gastroenterol. 2011 Mar;45(3):295-6. doi: 10.1097/MCG.0b013e3182040eb2.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Anti-Bacterial Agents / therapeutic use*
  • Crohn Disease / diagnosis
  • Crohn Disease / drug therapy*
  • Crohn Disease / immunology
  • Crohn Disease / microbiology
  • Female
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Remission Induction
  • Rifamycins / therapeutic use*
  • Rifaximin
  • Risk Factors
  • Rosacea / diagnosis
  • Rosacea / drug therapy*
  • Rosacea / immunology
  • Rosacea / microbiology
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Gastrointestinal Agents
  • Rifamycins
  • Rifaximin